• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Advair (fluticasone propionate and salmeterol xinafoate)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – January 2011

Advair HFA (fluticasone propionate and salmeterol xinafoate) Inhalation Aerosol

Advair Diskus (fluticasone propionate and salmeterol xinafoate inhalation powder)


Summary View



  • ... information about the risk of serious asthma outcomes (asthma related death, intubations, and hospitalization) ...